Reviews
Evidence-Based Reviews
Antidepressants for chronic pain
Certain agents may mitigate pain associated with neuropathy, fibromyalgia, headache, and IBS.
Evidence-Based Reviews
Older-age bipolar disorder: A case series
Age-related variations in presentation, treatment response may warrant a different approach.
Med/Psych Update
Differentiating serotonin syndrome and neuroleptic malignant syndrome
Symptoms can overlap, but accurate diagnosis is critical because treatments are distinct.
Pearls
Can taming inflammation help reduce aggression?
Inducing systemic inflammation has adverse effects on cognition and behavior, whereas suppressing inflammation can improve sensorium and mood.
Evidence-Based Reviews
Abuse of psychiatric medications: Not just stimulants and benzodiazepines
Anticholinergics, antidepressants, antipsychotics, and gabapentinoids may also be subject to misuse or abuse.
Evidence-Based Reviews
Injectable extended-release naltrexone for opioid dependence: 3 studies
Here we summarize 3 studies to describe which patients might be optimal candidates for XR-NTX, its success in comparison with BUP-NX, and...
Evidence-Based Reviews
Can lifestyle modifications delay or prevent Alzheimer’s disease?
Evidence suggests combining lifestyle modifications may yield better cognitive outcomes.
Evidence-Based Reviews
Botulinum toxin: Emerging psychiatric indications
Botulinum toxin has shown promising antidepressant effects, and might be helpful for several other indications.
Evidence-Based Reviews
Treating negative symptoms of schizophrenia
Few pharmacologic options, but evidence supports combining psychosocial interventions.
Out Of The Pipeline
Risperidone extended-release injectable suspension
RBP-7000 (Perseris) is the second long-acting injectable form of risperidone
approved in the United States.
Pearls
Urine drug screens: Not just for job applicants
Consider the urine drug screen as a tool for improving patients’ treatment adherence and clinical outcomes.